NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Unnatural Products

Unnatural Products

Private
Santa Cruz, CaliforniaHealthcare & Life Scienceshttps://www.unnaturalproducts.com/

Last Round

Series B

Mar 16, 2026

Total Funding Raised

$83M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Unnatural Products is a biotechnology company that offers a computational biology platform for engineering peptides aimed at traditionally undruggable targets, utilizing machine learning to optimize macrocyclic compounds and expedite the drug discovery process.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

macrocyclic peptidesdrug discovery platformoral therapeuticsAI drug discoveryundruggable targetsAI-guided designbiotech platformmolecular designoral bioavailabilitypharma partnershipin silico drug designcomputational biologypeptide engineeringdrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unnatural Products Comps

Public and private peers based on sector, stage, and business model.

Unnatural Products comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Unnatural Products Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 16, 2026
Series ADec 19, 2023
SeedSep 17, 2019

Key People

Founding team and executive leadership

Cameron Pye

CEO

Executive Team

Unnatural Products Investors

Notable investors and investment history

Unnatural Products investors
InvestorRounds
Rising Tide FundSeries A, Seed
Merck Global Health Innovation FundSeries B
Better VenturesSeries A, Seed
Blue Bear VenturesSeries A, Seed
GaingelsSeries A
ARTIS VenturesSeries B, Series A, Seed
Asset Management VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2026

    $45M round raised.

  • Feb 24, 2026

    Partnered with Novartis to develop cardiovascular therapies using AI.

Unnatural Products Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unnatural Products Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unnatural Products's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Cruz, California
Employee Range67
Year Founded2016
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.